Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products.
Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead candidates in various therapeutic areas, including CNS, endocrinology, cancer, and several debilitating orphan diseases. Kashiv plans to commercialize its products via strategic partnerships, and for select products, through the creation of an in-house specialized sales and marketing organization.
Mission & Vision
Our mission is to develop innovative drug delivery technologies, clinically differentiated products, and widely accessible biosimilars to improve patients’ lives.
Our vision is to become a global biopharmaceutical research and development company that develops, manufactures, and commercializes effective and affordable drug treatments to meet unmet medical needs.